Status:
COMPLETED
Combination of Serratus Anterior and Pectoral Nerve Blocks (PECS II) as Main Anesthetic Method in Breast Cancer Surgery
Lead Sponsor:
Samsun University
Conditions:
Anesthesia
Eligibility:
FEMALE
18-80 years
Brief Summary
Aim of this study is to determine the success of combined serratus anterior and PECS-2 block as the main anesthetic method in breast cancer surgery and also to investigate the patient acceptability of...
Detailed Description
Breast conserving surgery or mastectomy is applied in the surgical treatment of breast cancer. Axillary interventions range from sentinal lymph node biopsy to lymph node dissection. Clinically signifi...
Eligibility Criteria
Inclusion
- Patients between the ages of 18-80 and ASA I-III who will undergo unilateral breast cancer surgery will be included in the study.
Exclusion
- Patients with previous breast surgery other than excisional biopsy,
- coagulopathy,
- bleeding disease,
- local infection at the injection site,
- history of local anesthetic allergy,
- psychiatric disease (depression, mania, schizophrenia or antipsychotic drug use),
- history of opioid use for more than 4 weeks
- Patients with body mass index (BMI) \>40kg/m2 and
- chest deformity (pectus excavatum and pectus carinatum) will be excluded from the study.
Key Trial Info
Start Date :
July 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT05427292
Start Date
July 7 2022
End Date
July 7 2023
Last Update
July 10 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsun University
Samsun, Ilkadım, Turkey (Türkiye), 55100
2
Samsun University
Samsun, Turkey (Türkiye), 55040